Hyper Insight™ – DWI Infarct

Hyper Insight™ Stroke AI

One platform across the stroke pathway — hemorrhage, infarction, aneurysm, perfusion and 3D vascular imaging, on CT and MR. One solution is FDA-cleared today; seven more are in the FDA process. Select any solution for its description, capabilities, and performance evidence.

Hyper Insight™ – DWI Infarct

MR · DWIFDA & MFDS in ProgressPre-FDA Access

Detects and delineates suspected acute ischemic lesions on true acquired MR diffusion-weighted imaging, classifying each finding as vascular-territory or non-vascular-territory.

Capabilities
  • Infarct detection & segmentation — voxel-level delineation on DWI
  • Territory classification — vascular versus non-vascular territorial infarct
  • True MR-DWI input (acquired diffusion imaging)
  • Deep-learning sensitivity to small and punctate lesions
MRDWIInfarct Core Detectionreport.dcm
Representative Cases

DWI (left) · AI infarct overlay (right)

DWI with AI infarct overlay — representative case
DWI with AI infarct overlay — representative case
DWI with AI infarct overlay — representative case
DWI with AI infarct overlay — representative case
0.97
Sensitivity
0.96
Specificity
<80s
To Result
1,059
DWI Studies

Internal validation on an independent test set of 1,059 DWI studies (study-level analysis). Figures reflect internal analysis and are not a head-to-head comparison.

Performance & evidence

Sensitivity 0.97 · Specificity 0.96 · Processing under 80 seconds from series to result, on an independent test set.

⚠ Latest internal validation results

What it means clinically
  • True diffusion-weighted MR core detection — the gold-standard read for irreversible infarct, automated.